155 related articles for article (PubMed ID: 18191508)
1. Physical stability of ternary solid dispersions of itraconazole in polyethyleneglycol 6000/hydroxypropylmethylcellulose 2910 E5 blends.
Janssens S; Roberts C; Smith EF; Van den Mooter G
Int J Pharm; 2008 May; 355(1-2):100-7. PubMed ID: 18191508
[TBL] [Abstract][Full Text] [Related]
2. Characterization of ternary solid dispersions of itraconazole, PEG 6000, and HPMC 2910 E5.
Janssens S; de Armas HN; Roberts CJ; Van den Mooter G
J Pharm Sci; 2008 Jun; 97(6):2110-20. PubMed ID: 17847067
[TBL] [Abstract][Full Text] [Related]
3. Influence of polyethylene glycol chain length on compatibility and release characteristics of ternary solid dispersions of itraconazole in polyethylene glycol/hydroxypropylmethylcellulose 2910 E5 blends.
Janssens S; Denivelle S; Rombaut P; Van den Mooter G
Eur J Pharm Sci; 2008 Oct; 35(3):203-10. PubMed ID: 18656535
[TBL] [Abstract][Full Text] [Related]
4. Characterization of ternary solid dispersions of Itraconazole in polyethylene glycol 6000/polyvidone-vinylacetate 64 blends.
Janssens S; de Armas HN; D'Autry W; Van Schepdael A; Van den Mooter G
Eur J Pharm Biopharm; 2008 Aug; 69(3):1114-20. PubMed ID: 18502629
[TBL] [Abstract][Full Text] [Related]
5. The use of a new hydrophilic polymer, Kollicoat IR, in the formulation of solid dispersions of Itraconazole.
Janssens S; de Armas HN; Remon JP; Van den Mooter G
Eur J Pharm Sci; 2007 Mar; 30(3-4):288-94. PubMed ID: 17204410
[TBL] [Abstract][Full Text] [Related]
6. Thermodynamic and kinetic evaluation of the impact of polymer excipients on storage stability of amorphous itraconazole.
Zhang S; Lee TWY; Chow AHL
Int J Pharm; 2019 Jan; 555():394-403. PubMed ID: 30513399
[TBL] [Abstract][Full Text] [Related]
7. Design of spray dried ternary solid dispersions comprising itraconazole, soluplus and HPMCP: Effect of constituent compositions.
Davis MT; Potter CB; Mohammadpour M; Albadarin AB; Walker GM
Int J Pharm; 2017 Mar; 519(1-2):365-372. PubMed ID: 28131850
[TBL] [Abstract][Full Text] [Related]
8. Study of the phase behavior of polyethylene glycol 6000-itraconazole solid dispersions using DSC.
Wang X; Michoel A; Van den Mooter G
Int J Pharm; 2004 Mar; 272(1-2):181-7. PubMed ID: 15019081
[TBL] [Abstract][Full Text] [Related]
9. Solid state characteristics of ternary solid dispersions composed of PVP VA64, Myrj 52 and itraconazole.
Wang X; Michoel A; Van den Mooter G
Int J Pharm; 2005 Oct; 303(1-2):54-61. PubMed ID: 16105723
[TBL] [Abstract][Full Text] [Related]
10. Characterization and stability of solid dispersions based on PEG/polymer blends.
Bley H; Fussnegger B; Bodmeier R
Int J Pharm; 2010 May; 390(2):165-73. PubMed ID: 20132875
[TBL] [Abstract][Full Text] [Related]
11. A comparison of the effect of temperature and moisture on the solid dispersions: aging and crystallization.
Tian B; Zhang L; Pan Z; Gou J; Zhang Y; Tang X
Int J Pharm; 2014 Nov; 475(1-2):385-92. PubMed ID: 25218489
[TBL] [Abstract][Full Text] [Related]
12. Continuous production of itraconazole-based solid dispersions by hot melt extrusion: Preformulation, optimization and design space determination.
Thiry J; Lebrun P; Vinassa C; Adam M; Netchacovitch L; Ziemons E; Hubert P; Krier F; Evrard B
Int J Pharm; 2016 Dec; 515(1-2):114-124. PubMed ID: 27720874
[TBL] [Abstract][Full Text] [Related]
13. Application of film-casting technique to investigate drug-polymer miscibility in solid dispersion and hot-melt extrudate.
Parikh T; Gupta SS; Meena AK; Vitez I; Mahajan N; Serajuddin AT
J Pharm Sci; 2015 Jul; 104(7):2142-52. PubMed ID: 25917333
[TBL] [Abstract][Full Text] [Related]
14. Solid dispersions of itraconazole and enteric polymers made by ultra-rapid freezing.
Overhoff KA; Moreno A; Miller DA; Johnston KP; Williams RO
Int J Pharm; 2007 May; 336(1):122-32. PubMed ID: 17184938
[TBL] [Abstract][Full Text] [Related]
15. Characterization of solid dispersions of itraconazole and hydroxypropylmethylcellulose prepared by melt extrusion, Part II.
Six K; Berghmans H; Leuner C; Dressman J; Van Werde K; Mullens J; Benoist L; Thimon M; Meublat L; Verreck G; Peeters J; Brewster M; Van den Mooter G
Pharm Res; 2003 Jul; 20(7):1047-54. PubMed ID: 12880291
[TBL] [Abstract][Full Text] [Related]
16. Processing factors in development of solid solution formulation of itraconazole for enhancement of drug dissolution and bioavailability.
Kapsi SG; Ayres JW
Int J Pharm; 2001 Oct; 229(1-2):193-203. PubMed ID: 11604272
[TBL] [Abstract][Full Text] [Related]
17. Investigation of physicochemical factors affecting the stability of a pH-modulated solid dispersion and a tablet during storage.
Tran PH; Tran TT; Park JB; Min DH; Choi HG; Han HK; Rhee YS; Lee BJ
Int J Pharm; 2011 Jul; 414(1-2):48-55. PubMed ID: 21565260
[TBL] [Abstract][Full Text] [Related]
18. Development of a small-scale spray-drying approach for amorphous solid dispersions (ASDs) screening in early drug development.
Ousset A; Bassand C; Chavez PF; Meeus J; Robin F; Schubert MA; Somville P; Dodou K
Pharm Dev Technol; 2019 Jun; 24(5):560-574. PubMed ID: 30303440
[TBL] [Abstract][Full Text] [Related]
19. Preparation and characterization of solid dispersions of itraconazole by using aerosol solvent extraction system for improvement in drug solubility and bioavailability.
Lee S; Nam K; Kim MS; Jun SW; Park JS; Woo JS; Hwang SJ
Arch Pharm Res; 2005 Jul; 28(7):866-74. PubMed ID: 16114503
[TBL] [Abstract][Full Text] [Related]
20. Stability-enhanced hot-melt extruded amorphous solid dispersions via combinations of Soluplus® and HPMCAS-HF.
Alshahrani SM; Lu W; Park JB; Morott JT; Alsulays BB; Majumdar S; Langley N; Kolter K; Gryczke A; Repka MA
AAPS PharmSciTech; 2015 Aug; 16(4):824-34. PubMed ID: 25567525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]